198 related articles for article (PubMed ID: 27885451)
1. Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Sawazaki H; Ito K; Asano T; Kuroda K; Sato A; Asakuma J; Horiguchi A; Seguchi K; Asano T
World J Urol; 2017 Jul; 35(7):1081-1088. PubMed ID: 27885451
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.
Abufaraj M; Moschini M; Soria F; Gust K; Özsoy M; Mathieu R; Rouprêt M; Margulis V; Karam JA; Wood CG; Briganti A; Bensalah K; Haitel A; Shariat SF
World J Urol; 2017 Jul; 35(7):1073-1080. PubMed ID: 27830374
[TBL] [Abstract][Full Text] [Related]
3. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
[TBL] [Abstract][Full Text] [Related]
4. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
5. Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy.
Ito K; Kuroda K; Asakuma J; Hamada S; Tachi K; Tasaki S; Sato A; Horiguchi A; Seguchi K; Asano T
J Urol; 2014 Jun; 191(6):1685-92. PubMed ID: 24423440
[TBL] [Abstract][Full Text] [Related]
6. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
[TBL] [Abstract][Full Text] [Related]
7. Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival.
Kawamura K; Miyai K; Asakuma J; Sato K; Matsukuma S; Tsuda H; Ito K
Virchows Arch; 2021 Jul; 479(1):45-55. PubMed ID: 33404852
[TBL] [Abstract][Full Text] [Related]
8. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
9. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].
Wang Y; He HY
Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):681-686. PubMed ID: 27760608
[No Abstract] [Full Text] [Related]
11. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma.
Milojevic B; Dzamic Z; Kajmakovic B; Durutovic O; Bumbasirevic U; Sipetic Grujicic S
Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995
[TBL] [Abstract][Full Text] [Related]
12. Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival.
Dzamic Z; Milojevic B; Kajmakovic B; Grozdic Milojevic I; Bojanic N; Sipetic Grujicic S
Int Urol Nephrol; 2015 May; 47(5):775-9. PubMed ID: 25772384
[TBL] [Abstract][Full Text] [Related]
13. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.
Lee DJ; Xylinas E; Rieken M; Khani F; Klatte T; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Guo CC; Rioux-Leclercq N; Haitel A; Bolenz C; Bensalah K; Sagalowsky AI; Montorsi F; Lotan Y; Shariat SF; Robinson BD; Margulis V
Eur Urol; 2014 Aug; 66(2):379-85. PubMed ID: 24388440
[TBL] [Abstract][Full Text] [Related]
15. 8-armed octopus: Evaluation of clinicopathologic prognostic factors of urothelial carcinoma of the upper urinary system.
Ekmekçi S; Küçük Ü; Dere Y; Çakır E; Sayar HC; Ergani B; Çakmak Ö; Bozkurt O; Yörükoğlu K
Turk J Med Sci; 2019 Feb; 49(1):153-161. PubMed ID: 30764592
[TBL] [Abstract][Full Text] [Related]
16. Coincidental Bladder Cuff Transitional Cell Carcinoma in Nephroureterectomy Specimens: Risk Factors, Prognosis and Clinical Implementation.
Elawdy MM; Osman Y; Taha DE; El-Halwagy S; El-Mekresh M
Urol J; 2018 Sep; 15(5):256-260. PubMed ID: 29687437
[TBL] [Abstract][Full Text] [Related]
17. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
19. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
Favaretto RL; Bahadori A; Mathieu R; Haitel A; Grubmüller B; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Cunha IW; Zequi SC; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Jacquet-Kammerer S; Bensalah K; Lotan Y; Bachmann A; Rink M; Briganti A; Shariat SF
World J Urol; 2017 Jan; 35(1):113-120. PubMed ID: 27129576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
